Growth hormone response to clonidine is impaired in patients with central sympathetic degeneration.
Serum growth hormone (GH) levels before and after intravenous clonidine (1.5 mcg/Kg) were measured in normal subjects and patients with chronic idiopathic autonomic failure (AF) due to central sympathetic degeneration. Normal subjects showed a rise in plasma GH from 2 +/- 1 mU/l to 27 +/- 12 mU/l. Basal levels were similar but there was no rise in GH levels in the AF patients. There was no difference in sedation in the two groups, indicating similar central nervous system penetration of the drug. Systolic blood pressure fell in both groups. Diastolic blood pressure fell significantly in normals but not in the AF patients. Clonidine-induced growth hormone release may be a potentially useful neuroendocrine marker indicating derangement of certain components of the central alpha-adrenergic system in man.
D001342:Autonomic Nervous System Diseases / Q000503:physiopathology*; D001794:Blood Pressure; D003000:Clonidine; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D007024:Hypotension, Orthostatic / Q000503:physiopathology; D012083:Renin / Q000097:blood; D012791:Shy-Drager Syndrome / Q000503:physiopathology
D013006:Growth Hormone; D012083:Renin; D003000:Clonidine